Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study | LANCET ONCOLOGY |